Copenhagen, Denmark; December 2,
2005 – Genmab A/S (CSE: GEN) on December 1 granted 23,250 warrants
to new employees.
The exercise price for each warrant is DKK 130.00. Each warrant entitles
the owner to subscribe one share of nominally DKK 1.
On the basis of an exercise price of DKK 130.00 and by application of the
Black-Scholes formula, the value of each warrant can be calculated as DKK
45.82 based on an interest rate of 3.09% and the historical volatility of
Genmab A/S shares calculated at 32.79%.
The warrants vest in blocks of 25% one, two, three and four years after the
grant date, and all warrants expire at the tenth anniversary of the grant
date. Information concerning the company’s warrant schemes can be found at
www.genmab.com under the heading ‘warrant scheme.’